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A TWO-DIMENSIONAL MARKOV MODEL WITH
DIFFERENT CYCLE LENGTHS FOR A CHRONIC
CONDITION WITH SLOW IRREVERSIBLE
DISEASE PROGRESSION AND RECURRENT
PERIODS OF SEVERE SYMPTOMS
Borg S, Ericsson Å
AstraZeneca R&D Lund, Lund, Sweden
OBJECTIVES: To construct a health economic model 
for a chronic condition with slow irreversible disease pro-
gression (slow process) and recurrent periods of severe
symptoms (rapid process), processes which are depen-
dent. We wish to study changes to either process or both
simultaneously.
METHODS: The processes are dependent; more pro-
gressed patients have more frequent and worse attacks,
more frequent attacks lead to accelerated progress. Esti-
mating short-term transition probabilities for the slow
process is difﬁcult, suggesting a time-scale with long
cycles. However, long cycles are irrelevant for the rapid
process, thus suggesting short cycles. Denote the progress
with a discrete scale of increasing progress, 1, 2, . . . , and
attacks 0 = no attack, and 1 = ongoing attack.
RESULTS: We use a two-dimensional discrete time
Markov model, disease progression in dimension Y and
attacks in dimension X. The probability of X depends on
the previous X and Y, and vice versa for Y. Hence the
dependence between X and Y can be modeled. Costs and
outcomes are estimated using state and transition
rewards, enabling health economic analysis. Updating X
more frequently (e.g. weekly) than Y (e.g. yearly) gives
relevant cycle lengths. Y updates in outer cycles, and X
updates in inner cycles. X’s dependence on Y is straight-
forward, but Y’s dependence of X makes it necessary to
summarise outcomes in the inner cycle, to inform update
in the outer cycles. The type of summary depends on the
evaluation method, e.g. Monte Carlo simulation requires
total time in X = 0 and X = 1 to estimate the progression
risk since it depends on X.
CONCLUSIONS: Using cycle lengths relevant for each of
the processes improves transition probability estimates in
terms of predicting observed outcomes. This compensates
for increased error due to different update rates. The face
validity of the model may be improved by using relevant
cycle lengths for the processes.
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PSYCHOMETRIC PROPERTIES OF THE HEALTH
RELATED QUALITY OF LIFE INSTRUMENT IN
THE MEDICAL EXPENDITURE PANEL SURVEY
Shetty VL, Crawford SY, Conrad KJ, Lambert BL,
Woodward J
University of Illinois at Chicago, Chicago, IL, USA
Health Related Quality of Life (HRQL) is viewed as 
an important health outcomes indicator, particularly for
decision-making. Well-established high psychometric
properties of HRQL instruments are key in their selection
for research purposes.
OBJECTIVES: This study determined the psychometric
properties of the HRQL instrument used in the Medical
Expenditure Panel Survey (MEPS) and offered recom-
mendations about its use.
METHODS: The psychometric properties investigated
were reliability (internal consistency) and validity (con-
tent, construct, and known groups). Content validity was
estimated by comparison with established HRQL instru-
ments e.g. SF-36 and others. Construct validity was esti-
mated by factor analysis using the principal components
method and internal consistency was established using
Cronbach’s alpha. Known groups validity of the HRQL
scores was estimated by one-way analysis of variance
(ANOVA) and post hoc Tukey’s HSD using age groups
and perceived general health status as the independent
variables.
RESULTS: The HC-005 measures four of the most fre-
quently represented health concepts (physical function-
ing, social functioning, role functioning and health
perceptions). The factor analysis indicated that the instru-
ment measured two underlying constructs—Physical
Functioning and Activities of Daily Living (ADL). The
instrument had a high overall internal consistency (0.85).
The Physical Functioning and ADL scales had high (0.87)
and good (0.67) internal consistency respectively. The
scales scores did not show any ﬂoor and ceiling effects.
ANOVA indicated that the scales were able differentiate
between age groups and perceived general health
responses.
CONCLUSIONS: The MEPS HRQL instrument has a
reasonably good design and broad scales that capture
HRQL domains such as Physical Functioning and ADL’s.
The ﬁndings demonstrate good to average psychometric
proﬁles for this instrument. There is still further need to
establish the psychometric properties of this instrument
for health care decision making.
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EVALUATING THE USE OF PROBABILISTIC
SENSITIVITY ANALYSIS VIA MONTE CARLO
SIMULATION (MCS):AN AUDIT OF THE HEALTH
ECONOMIC LITERATURE
Botteman M, Bell C, Stephens J
Abt Associates Clinical Trials, Bethesda, MD, USA
OBJECTIVES: Probabilistic sensitivity analysis (PSA)
using MCS is one method of addressing parameter uncer-
tainty within health economic models. Although broad
recommendations (e.g., from ISPOR) exist on the appro-
priate use of these techniques, practical guidance regard-
ing their application remains limited. We surveyed the
literature to assess how PSA has been applied, how trans-
parent these methods have been, and to provide some
guidance for their future use.
METHODS: A MEDLINE search identiﬁed articles men-
tioning “PSA” or “MCS AND cost” between 1966 and
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2001. The survey focused on a subset of applied articles
in English, after excluding methodological, environmen-
tal or veterinarian studies, and those not reporting cost
data. Finally, articles employing MCS for purposes other
than conducting PSA were excluded. Descriptive analyses
were used to evaluate their methods.
RESULTS: Of the 319 articles identiﬁed, 39 met the 
inclusion/exclusion criteria. Of these 39 studies, 64%
were published after 1998. PSA was commonly used to
reﬂect uncertainty regarding probabilities or costs, but
less commonly for utilities. When applicable, the distrib-
ution type was speciﬁed for 42%, 56%, and 64% of
utility, cost, and probability parameters, respectively.
Sixty-one percent of studies used uniform, triangular or
normal distributions. Justiﬁcation for the distribution
type was inconsistently reported. Only 8% of studies
assumed some correlation between parameters or pre-
sented absolute worst- or best-case scenarios, which the-
oretically bound all possible simulation results. Over
70% of studies used acceptability thresholds or curves for
reporting cost-effectiveness results.
CONCLUSIONS: Our survey indicates that the use of
PSA is increasingly popular. However, how these methods
have been applied has rarely been sufﬁciently transpar-
ent. PSA is relatively new in health economics and studies
employing this technique should provide transparent
descriptions of their methods. This will improve the
acceptability and usefulness of PSA, while providing 
guidance to analysts wishing to use this powerful 
methodology.
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LITERATURE REVIEW OF GUIDELINES FOR
CROSS-CULTURAL ADAPTATION OF HRQL
MEASURES: UPDATED RESULTS
Conway K, Mear I,Acquadro C
Mapi Research Institute, Lyon, France
In response to European regulators’ concern about the
methodology followed to translate and achieve cultural
adaptation of Health-related Quality of Life (HRQL)
instruments (i.e. the process of adapting a measure from
a source to a target language), the ERIQA Group has inte-
grated the development of regulators-targeted guidance
documents for cross-cultural adaptation into their pro-
gramme. The ﬁrst step in collaboration with Mapi
Research Institute has been to investigate current 
guidelines.
OBJECTIVES: To identify and analyse the methods used
for cultural adaptation of HRQL instruments.
METHODS: Medline and Embase were searched using
the keywords “quality of life”, “questionnaires”, “health
status indicators” which were matched with “translating”
and “cross-cultural comparison”. Papers published
between January 1966 and April 2001 were taken into
consideration. 173 references were identiﬁed. Mapi
Research Institute’s database was searched using “trans-
lation issues”, “cross-cultural comparison”, and “cross-
cultural research”, with 236 references as a result. 409
abstracts were reviewed. Inclusion criteria were: 1) the
paper should propose guidelines/recommendations or 2)
it should review and analyse methods.
RESULTS: 32 papers met with the inclusion criteria. 14
sets of guidelines were identiﬁed. A lack of consensus
emerged about: a) the terminology qualifying the process
of adapting a HRQL instrument from source to target
language, and b) the scope covered by this terminology.
Similarities included multiple forward translations, 
reconciliation sessions, and some form of back-
translations. Differences appeared in the importance
given to back-translation, forms of panel testing, and
translators’ recruitment criteria. Few articles compared
methodologies.
CONCLUSION: This review shows disparity in deﬁni-
tions and methods. Further investigations may be needed
in order to explore empirical evidence of the methods’
effectiveness, and propose recommendations for 
regulators.
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A LOGICAL PROBLEM IN VIEWING UTILITY
THEORY AS NORMATIVE
Gagnon DD
Johnson & Johnson Pharmaceutical Research and
Development, L.L.C, Raritan, NJ, USA
OBJECTIVES: Evaluate the claim that Utility Theory
(UT) is normative.
METHODS: Logical analysis of UT and normative
injunctions. The positive/normative distinction is between
“is” and “ought.” Positive statements describe how
things are; normative injunctions (e.g., “First, cause no
harm”) request that we act in certain ways. The norma-
tive interpretation of UT suggests that we should act so
as to maximize our utility.
RESULTS: The normative interpretation of UT leaves 
the individual with a decision to make: “Should I act so
as to maximize my utility?” If the individual applies UT
as a decision procedure to answer this question, then an
afﬁrmative answer to the question is being assumed and
not proved. Alternatively, the individual could attempt to
justify the use of UT by appealing to a more general deci-
sion procedure. But if the more general decision proce-
dure can decide this question, then why use UT at all?
The more general decision procedure could be used in the
place of UT to decide everyday questions. But, then, the
more general decision procedure requires justiﬁcation. To
justify its use, we must appeal to an even more general
decision procedure. So, we embark upon an inﬁnite
regress when trying to justify UT by appealing to more
general decision procedures. The logical problem with the
normative view of UT does not carry over to medical deci-
sion making in general, where an external criterion is used
as an indicator for a particular characteristic. Vis a vis
medical decision making, the logical problem with the
